NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it has acquired privately held antibody maker Affinity BioReagents for an undisclosed amount.
Golden, Colo.-based Affinity makes monoclonal and polyclonal antibodies, peptides, proteins, and other reagents. The firm, which offers more than 35,000 reagents, also provides recombinant proteins and custom antibody-production services, said Thermo Fisher.
Affinity had around $6 million in revenues in 2007 and will be integrated into Thermo Fisher’s Analytical Technologies segment.
The deal follows Thermo Fisher’s acquisition a couple of weeks ago of Open Biosystems, a privately held provider of RNAi research products, for an undisclosed sum.